Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial (Q36231929)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial |
scientific article |
Statements
1 reference
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial (English)
1 reference
Mark Emberton
1 reference
Christian G Stief
1 reference
Derek J Rosario
1 reference
Eric Barret
1 reference
Abdel-Rahmène Azzouzi
1 reference
Sébastien Vincendeau
1 reference
Antony Cicco
1 reference
François Kleinclauss
1 reference
Henk G van der Poel
1 reference
Jens Rassweiler
1 reference
Georg Salomon
1 reference
Eduardo Solsona
1 reference
Antonio Alcaraz
1 reference
Teuvo T Tammela
1 reference
Francisco Gomez-Veiga
1 reference
Göran Ahlgren
1 reference
Fawzi Benzaghou
1 reference
Bertrand Gaillac
1 reference
Billy Amzal
1 reference
Frans M J Debruyne
1 reference
Gaëlle Fromont
1 reference
Christian Gratzke
1 reference
PCM301 Study Group
1 reference
19 December 2016
1 reference
1 reference
18
1 reference
2
1 reference
181-191
1 reference
Identifiers
1 reference
1 reference